The Long Run with Luke Timmerman

A podcast by Timmerman Report

173 Episodes

  1. Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader

    Published: 7/26/2021
  2. Ep94: Jenny Rooke on Investing in Biotech Tools

    Published: 7/19/2021
  3. Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists

    Published: 6/14/2021
  4. Ep92: Brad Gray on Spatial Biology

    Published: 6/1/2021
  5. Ep91: Daphne Zohar on Biotech Entrepreneurship

    Published: 5/3/2021
  6. Ep90: James Sabry on Partnering Amid Scientific Abundance

    Published: 4/19/2021
  7. Ep89: Emily Leproust on DNA Synthesis at Scale

    Published: 3/29/2021
  8. Ep88: Amy DuRoss on software and logistics for cell and gene therapy

    Published: 3/15/2021
  9. Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

    Published: 3/1/2021
  10. Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

    Published: 2/9/2021
  11. Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

    Published: 1/20/2021
  12. Ep84: Steve Paul on Treatments for Mental Health

    Published: 12/22/2020
  13. Ep83: David Lee on Impact in Pharmaceuticals

    Published: 12/14/2020
  14. Ep82: Andrew Farnum on Medicines From Unusual Traits

    Published: 11/23/2020
  15. Ep81: Simba Gill on Microbiome Therapies

    Published: 11/12/2020
  16. Ep80: Peter Kolchinsky on Pharma's Soul

    Published: 10/28/2020
  17. Ep79: Daphne Koller on Machine Learning for Drug Discovery

    Published: 10/26/2020
  18. Ep78: Pearl Huang on Exoneural Cancer Biology

    Published: 10/13/2020
  19. Ep77: Jennifer Petter on Drugging RNA Targets

    Published: 9/29/2020
  20. Ep76: Otello Stampacchia on Becoming a Biotech VC

    Published: 9/8/2020

5 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.